These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Bortezomib-induced cutaneous lesions in multiple myeloma patients: a case report. Rodríguez-Martín M; Sáez-Rodríguez M; García-Bustínduy M; Martín-Herrera A; Noda-Cabrera A Dermatol Online J; 2008 Nov; 14(11):14. PubMed ID: 19094852 [TBL] [Abstract][Full Text] [Related]
8. Late onset of bortezomib-associated cutaneous reaction following herpes zoster. Varettoni M; Vassallo C; Borroni G; Mangiacavalli S; Zappasodi P; Rosso R; Lazzarino M; Corso A Ann Hematol; 2007 Apr; 86(4):301-2. PubMed ID: 17131123 [No Abstract] [Full Text] [Related]
9. Cutaneous lymphoid perivascular reaction with atypical CD30+ T cells in a patient with multiple myeloma treated with bortezomib. Dehesa L; Bastida J; Limeres-González M; Campos-Adsuar C; Gómez-Duaso J Clin Exp Dermatol; 2009 Dec; 34(8):e1031-2. PubMed ID: 20055832 [No Abstract] [Full Text] [Related]
17. Neutrophilic dermatitis associated with bortezomib in a patient with multiple myeloma. Paiva CM; Kurtis B; Mekki M; Newman MA; Singhal S; Lacouture ME Ann Oncol; 2007 Oct; 18(10):1744-5. PubMed ID: 17890215 [No Abstract] [Full Text] [Related]
18. Pulmonary fibrosis in a myeloma patient on bortezomib treatment. A new severe adverse effect of a new drug. Duek A; Feldberg E; Haran M; Berrebi A Am J Hematol; 2007 Jun; 82(6):502-3. PubMed ID: 17301973 [No Abstract] [Full Text] [Related]
19. Bortezomib-induced neurogenic bladder in patients with multiple myeloma. Shimura K; Shimazaki C; Taniguchi K; Inaba T; Horiike S; Taniwaki M Ann Hematol; 2009 Apr; 88(4):383-4. PubMed ID: 18836719 [No Abstract] [Full Text] [Related]